As of November 2024, Hybio Pharmaceutical has a market cap of $1.12B. This makes Hybio Pharmaceutical the world's 7331th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.33B | -21.50% |
2023 | $1.69B | -22.75% |
2022 | $2.19B | 39.41% |
2021 | $1.57B | 89.62% |
2020 | $829.52M | 14.66% |
2019 | $723.49M | -37.90% |
2018 | $1.17B | -42.63% |
2017 | $2.03B | -9.45% |
2016 | $2.24B | -27.00% |
2015 | $3.07B | 82.44% |
2014 | $1.68B | 27.36% |
2013 | $1.32B | 207.47% |
2012 | $430.04M | - |